The Discounted Cash Flow (DCF) valuation of US Stem Cell Inc (USRM) is (0.13) USD. With the latest stock price at 0.00 USD, the upside of US Stem Cell Inc based on DCF is -133146.6%.
Based on the latest price of 0.00 USD and our DCF valuation, US Stem Cell Inc (USRM) is a sell. selling USRM stocks now will result in a potential gain of 133146.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 3.1% - 5.6% | 4.3% |
| Long-term Growth Rate | 2.0% - 2.8% | 2.4% |
| Fair Price | (0.90) - (0.08) | (0.13) |
| Upside | -901685.4% - -79362.0% | -133146.6% |